Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Healthcare (Basel, Switzerland)|December 23, 2022
Current Considerations in Surgical Treatment for Adolescents and Young Women with Breast CancerBrittany L Murphy, Alicia Pereslucha, Judy C Boughey
Clinical Breast Cancer|February 7, 2017
Nipple-sparing Mastectomy for the Management of Recurrent Breast CancerBrittany L Murphy, Judy C Boughey, Tina J Hieken
American Journal of Surgery|March 3, 2019
Returns to the operating room after breast surgery at a tertiary care medical centerBrittany L Murphy, Amy E Glasgow, Elizabeth B Habermann, et al.
Journal of Pediatric and Adolescent Gynecology|October 15, 2017
Surgical Treatment of Adolescent Breast Disorders: Institutional Experience and National TrendsBrittany L Murphy, Amy E Glasgow, Dan S Ubl, et al.
Annals of Surgical Oncology|July 29, 2020
Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel TestingBrittany L Murphy, Min Yi, Banu K Arun, et al.
Annals of Surgical Oncology|August 23, 2017
Incorporation of Treatment Response, Tumor Grade and Receptor Status Improves Staging Quality in Breast Cancer Patients Treated with Neoadjuvant ChemotherapyJohn R Bergquist, Brittany L Murphy, Curtis B Storlie, et al.
Annals of Surgical Oncology|August 3, 2017
Selective Use of Sentinel Lymph Node Surgery in Patients Undergoing Prophylactic Mastectomy Using Intraoperative PathologyBrittany L Murphy, Amy E Glasgow, Gary L Keeney, et al.
European Journal of Radiology|March 8, 2017
Cross-sectional imaging to evaluate the extent of regional nodal disease in breast cancer patients undergoing neoadjuvant systemic therapyTara L Anderson, Katrina N Glazebrook, Brittany L Murphy, et al.
Annals of Surgical Oncology|August 4, 2019
Adolescents and Young Adults with Breast Cancer have More Aggressive Disease and Treatment Than Patients in Their FortiesBrittany L Murphy, Courtney N Day, Tanya L Hoskin, et al.
Annals of Surgical Oncology|May 23, 2018
Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ SubtypesBrittany L Murphy, Courtney N Day, Tanya L Hoskin, et al.
Pageof 4